C8orf87

Across TCGA pan-cancer cohorts, C8orf87 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated C8orf87 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher C8orf87 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated C8orf87 expression acts as an unfavorable survival marker, although some lineages such as MESO and UCS show a favorable association.

THCA, STAD, and ACC are the cancer types where C8orf87 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	DFS	Tertile	All	0.554	0.836	<.001	129	view →
STAD	OS	Quartile	All	0.448	0.636	<.001	90	view →
ACC	OS	Tertile	II,III,IV	0.208	0.804	<.001	54	view →
READ	OS	Tertile	III,IV	0.367	0.851	<.001	47	view →
THYM	DFS	Tertile	All	0.445	0.934	<.001	45	view →
MESO	OS	Quartile	All	0.560	0.324	.003	32	view →
UCS	DFS	Quartile	II,III,IV	0.733	0.338	.011	28	view →
ESCA	DFS	Quartile	III,IV	0.884	0.266	.005	21	view →
LIHC	OS	Tertile	All	0.584	0.807	.003	21	view →
GBM	OS	Tertile	All	0.254	0.452	.026	18	view →
UVM	OS	Tertile	All	0.292	0.674	.035	18	view →
LAML	DFS	Tertile	All	0.237	0.588	.018	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

C8orf87–THCA (DFS)

Open the THCA breakdown →